RoActemra

Active ingredient
Etanercept, Adalimumab, Tocilizumab, Abatacept, Canakinumab
Pharma Company
Roche Pharma AG/ Roche Deutschland Holding GmbH
Total Number of Doctors1
176 doctors
Total Number of Patients2
6,846 patients
Total minimum fees planned3
5,051,662.00 €

Observational Studies including RoActemra

Drug No. of doctors1 No. of patients2 Payment per patient3
RoActemra® s.c. 80 2,000 834.59 € 10 Dokumentationen
RoActemra 22 102 871.00 € entspricht 67 €/h + einmalig für 268€ Schulung
RoACTEMRA 39 167 770.00 € Eingangsdokumentation: 140€, Folgedokumentationen: 70€ (nach GOÄ: Gutachten * 2,3)
RoACTEMRA 1 1,000 840.00 € pro ordnungsgemäß ausgefülltem Dokumentationsbogen , bei Ablieferung der vereinbarten maximalen 4 Dokumentationsbögen, max 12 Patienten
RoACTEMRA n/a n/a 1,100.00 € pro ausgefülltem Dokumentationsbogen , bei Ablieferung der vereinbarter maximalen Anzahl von 10 Dokumentationsbögen ergibt sich ein Gesamtbetrag von 11.000 €, aufgeschlüsselt im Beobachtungsbogen und Vertrag
Biologika (Enbrel, Humira, RoActemra, Orencia, Ilaris) 34 3,577 650.00 € über 5 Jahre (50,00 pro Dokumentation)

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.